Venture Life Science Focus Burrill & Company is a specialized global financial services firm with deep life sciences industry exposure, presenting opportunities to cross-sell advanced financial solutions, strategic advisory, and capital raising services to closely aligned biotech, medical device, and pharma clients.

AUM Growth Potential With 1.5 billion in assets under management and a diversified platform including venture capital, private equity, and merchant banking, there is potential to expand relationships with portfolio companies seeking growth capital, liquidity events, or secondary market strategies.

Global Reach Headquartered in San Francisco with offices across the US, Latin America, Europe, and Asia, Burrill & Company can facilitate cross-border financings, strategic partnerships, and market-entry support for international life sciences ventures.

Tech & Data Enablement The tech stack indicates investment in digital infrastructure and data-driven capabilities; this presents upsell opportunities for relationship management platforms, data analytics, and investor communications tools to enhance deal sourcing and portfolio monitoring.

Market Positioning Strong industry visibility through conferences, publications, and networks gives access to senior decision-makers in life sciences, enabling tailored outreach for advisory, syndication, and co-investment opportunities with Burrill & Company’s ecosystem.